{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"PancChat Podcast with Alisyn Camerota","title":" Clinical Trials for Pancreatic Cancer ","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/82f3c6a3\"></iframe>","width":"100%","height":180,"duration":1275,"description":"How do doctors decide when to use standard chemotherapy, explore immunotherapy, or recommend a clinical trial? In this episode of PancChat, host Alisyn Camerota speaks with Dr. Andrew Hendifar about how tumor sequencing, genetic testing, and emerging KRAS-targeted therapies are reshaping pancreatic cancer care. They discuss the challenges patients face navigating clinical trials, why timing and advocacy are critical, and why — despite the daunting diagnosis — there’s more reason for hope today than ever before.Dr. Andrew Hendifar heads the Gastrointestinal Disease Research Group and founded their Hematology and Oncology Fellowship Program at Cedars-Sinai Medical Center in Los Angeles. He works with SWOG and the NIH’s Neuroendocrine Tumor Task Force., Dr. Hendifar is a member of PanCAN’s Scientific and Medical Advisory Board. Learn more about how clinical trials work on the Let’s Win What Is a Clinical Trial? Page or PanCAN’s Clinical Trials page.You can explore available clinical trials through the Let’s Win’s Trial Finder or the PanCAN Clinical Trial Finder. For a personalized search, PanCAN’s Patient Services is also here to help. ","thumbnail_url":"https://img.transistorcdn.com/cAJEAPlDE1maKBGcgHeLPBFdNegZ6bz0Ol0rS-Dsvj0/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mZThh/MzliZmRmOThiY2U5/ZGNlNWI0MGE2Mjdj/NDkzMy5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}